Every AI newsletter asks investors to ask questions on the investor interaction platform: Hello, honorable secretaries, Tsinghua University announced that the COVID-19 test reagent PCR method has been listed. Your company is the leading enterprise in vitro reagent diagnosis in China. Is New Coronavirus’s nucleic acid detection PCR and Tsinghua University’s same reagent?
Shanghai Kehua Bio-Engineering Co.Ltd(002022) (002022. SZ) said on the investor interaction platform on January 23 that the nucleic acid detection reagent produced by our company adopts fluorescence PCR method, while the nucleic acid detection reagent developed by Tsinghua University adopts digital PCR method.
